Kinase inhibitor offers new option for thyroid cancerAgent delays disease progression in radioiodine-resistant disease Antibody extends survival in lung cancerRamucirumab shows promise as second-line agent Why are too many women choosing mastectomy? Canadian study shows experiences of family and friends outweigh surgeons’ advice New cancer treatment danger: Pills vulnerable to gastric acid suppression Canadian researchers find proton pump inhibitors are linked with reduced survival in patients on oral anticancer agents ASA: Cancer fighter Biomarkers explain inconsistent results in colorectal cancer prevention Prostate screening guideline crosses border Canadian study suggests biopsy rates have been dropping since U.S. task force report Hypertension occurs in most patients receiving VEGF inhibitor therapy for cancer Guidelines needed to improve hypertension management without affecting cancer response. Sildenafil linked with melanoma FDA advisers unanimously back Cologuard, a DNA test for colon cancer Experimental therapies target chronic lymphocytic leukemia Monoclonal antibody and kinase inhibitor yield promising results in recent trials First Previous 32 33 34 35 36 Next Last